## Pathophysiology of PPI-Induced B12 Deficiency ### Clinical Presentation The patient presents with classic B12 deficiency signs: - **Hematologic**: Microcytic anemia (though B12 deficiency typically causes macrocytic anemia, chronic iron deficiency from achlorhydria can cause microcytosis) - **Neurologic**: Paresthesias, glossitis (dorsal column involvement) - **Biochemical**: Low B12, normal folate, atrophic gastritis on endoscopy **Key Point:** Long-term PPI use (>5 years) is a recognized risk factor for B12 deficiency. The mechanism is NOT direct inhibition of intrinsic factor, but rather impaired B12 release and reduced intrinsic factor production due to chronic gastric acid suppression. ### Mechanism of PPI-Induced B12 Deficiency ```mermaid flowchart TD A[PPI blocks H+ secretion]:::action --> B[Chronic achlorhydria pH > 3]:::outcome B --> C[Food-bound B12 not released<br/>from proteins]:::outcome B --> D[Atrophic gastritis develops<br/>fewer parietal cells]:::outcome D --> E[Reduced intrinsic factor<br/>production]:::outcome C --> F[B12 malabsorption<br/>in terminal ileum]:::urgent E --> F F --> G[B12 deficiency anemia<br/>+ neuropathy]:::urgent ``` ### Step-by-Step Mechanism 1. **Acid suppression**: PPIs reduce gastric H⁺ to pH > 3 (normal fasting pH 1.5–3.5) 2. **Impaired B12 release**: Dietary cobalamin is bound to food proteins. Gastric acid and pepsin are required to cleave these bonds. Without adequate acid, B12 remains protein-bound and unavailable for absorption 3. **Reduced intrinsic factor**: Chronic achlorhydria triggers atrophic gastritis, destroying parietal cells and reducing intrinsic factor production 4. **Malabsorption**: Even free B12 cannot be absorbed without intrinsic factor in the terminal ileum 5. **Clinical deficiency**: After 2–5 years of PPI use, B12 stores deplete, causing anemia and neurologic complications **High-Yield:** The key distinction: PPIs do NOT directly block intrinsic factor synthesis acutely. Instead, they cause achlorhydria → atrophic gastritis → loss of parietal cells → reduced intrinsic factor over time. This is why B12 deficiency is a late complication of long-term PPI use. ### Clinical Pearl **Mnemonic — PPI Complications (Long-term):** **CHAMP** - **C**alcium malabsorption (hypocalcemia, osteoporosis) - **H**ypomagnesemia (arrhythmias, tetany) - **A**trophic gastritis (B12 deficiency, pernicious anemia) - **M**agnesium depletion - **P**ancreatic insufficiency (rare) B12 deficiency is one of the most clinically significant long-term PPI adverse effects. ### Comparison: B12 Deficiency Causes | Cause | Mechanism | Intrinsic Factor | Gastric Acid | Reversibility | |-------|-----------|------------------|--------------|---------------| | PPI use | Achlorhydria → atrophic gastritis | ↓ (secondary) | ↓ | Partially reversible if stopped early | | Pernicious anemia | Autoimmune destruction of parietal cells | ↓ (primary) | ↓ | Irreversible; requires B12 injections | | Gastrectomy | Surgical removal of parietal cells | ↓ (permanent loss) | ↓ | Irreversible; requires B12 supplementation | | Dietary deficiency | Inadequate intake (vegans) | Normal | Normal | Reversible with dietary change or supplementation | ### Why Not the Other Options? **Option 0 (Direct inhibition of intrinsic factor)**: PPIs do not directly suppress intrinsic factor synthesis. The reduction is secondary to atrophic gastritis and parietal cell loss over time. **Option 2 (Omeprazole binds B12)**: Omeprazole does not sequester cobalamin. It reduces acid, which impairs B12 release from food proteins. **Option 3 (Permanent parietal cell destruction)**: While PPI-induced atrophic gastritis is serious, it is NOT as irreversible as autoimmune pernicious anemia. Early PPI cessation may allow some recovery of parietal cell function, though B12 stores must be repleted.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.